Source: IndiaMedToday

Pierre Fabre: Jubilant Biosys seals deal with Pierre Fabre

To acquire R&D centre at Saint-Julien-en-Genevois, France and add drug discovery and preclinical development capabilities in biologics and antibody drug conjugate Jubilant Biosys Innovative Research Services, Singapore (JBIRSPL), a subsidiary of Jubilant Biosys, a wholly owned subsidiary of Jubilant Pharmova, has executed the transaction definitive agreements with Pierre Fabre, and its affiliate entities (PF), for [...]

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
10-50K
Eric Ducournau's photo - CEO of Pierre Fabre

CEO

Eric Ducournau

CEO Approval Rating

77/100

Read more